Patents
Patents for A61K 35 - Medicinal preparations containing material or reaction products thereof with undetermined constitution (125,838)
06/2004
06/02/2004EP0807178B1 Mycobacterial proteins, microorganisms producing same and uses of said proteins in vaccines and for detecting tuberculosis
06/02/2004CN1501937A Spiro-pyrimidine-2,4,6-trione metalloproteinase inhibitors
06/02/2004CN1501805A Endotoxin binding by lactic acid bacteria and bifidobacteria
06/02/2004CN1501084A Reagent red blood cell
06/02/2004CN1500532A Product capable of emitting far infrared and method of using far infrared
06/02/2004CN1500495A Use of dictyoptera grease in healthcare food and medicine , its preparation method
06/02/2004CN1151835C Medicine for treating tumor
06/02/2004CN1151832C Traditional Chinese medicine composition for treating ischemic cardio-cerebral vascular disease and peripheral vascular disease
06/02/2004CN1151829C Medicine for treating lymphatic tuberculosis and lymphoma
06/02/2004CN1151828C Medicine for treating bone fracture and preparation method
06/02/2004CN1151827C Dressed plaster for treating facial palsy and its preparation
06/02/2004CN1151820C Traditional Chinese medicine for treating rheumatic heart disease
06/02/2004CN1151819C Cerebral thrombus treating traditional Chinese medicine
06/02/2004CN1151818C Diabetes treating traditional Chinese medicine
06/02/2004CN1151817C Fracture setting granule for treating bone injury and its preparation process
06/02/2004CN1151816C Fracture setting capsule of traditional Chinese medicine for treating bone injury and its preparation process
06/02/2004CN1151815C Capsule for treating hepatic disease
06/02/2004CN1151810C Face-beautifying face-nourishing capsule and preparation method
06/02/2004CN1151809C Medicine of treating coronary heart disease and coronarism ,and its preparation method
06/02/2004CN1151806C Capsule for curing cholecystitis,gall bladder, pancreatitis,icterohepatitis
06/02/2004CN1151803C Prepared traditional Chinese medicine for treating cancer
06/02/2004CN1151802C Capsule for invigorating function of brain and its preparing process
06/02/2004CN1151801C Traditional Chinese medicine for treating cardiovascular and cerebrovascular diseases
06/02/2004CN1151799C Bacterial membrane fractions with adjuvant effect
06/02/2004CN1151798C 活性双歧杆菌胶囊 Active Bifidobacterium Capsules
06/02/2004CN1151797C Tumor-blood-vessel growth inhibitor and medicinal composition
06/02/2004CN1151796C Remedy and preparation process of medicine for treating burns and scalds
06/01/2004US6743626 Artificial salivary gland
06/01/2004US6743598 Methods for the identification of fungal glucose utilization inhibitors and antifungal agents
06/01/2004US6743577 Methods of using cyanovirins to inhibit viral infection
06/01/2004US6743574 For improved durability, function, and recellularization post-implantation
06/01/2004US6743435 Processing animal tissues by decellularizing, increasing surface area and acylating
06/01/2004US6743423 Intratumorally administering effective amount of adeno-associated virus-2 in combination with chemotherapeutic agent for small cell lung or pancreatic cancer to lower chemotherapy resistance
06/01/2004US6743192 Concentrated platelets; separating according to density
06/01/2004CA2075720C Hemorroanzi
05/2004
05/29/2004CA2451584A1 Modified cdna factor viii and its derivatives
05/27/2004WO2004044186A1 Probiotic additive and the production method thereof
05/27/2004WO2004044164A2 Method for identifying risk of melanoma and treatments thereof
05/27/2004WO2004044163A2 Methods for identifying risk of melanoma and treatments thereof
05/27/2004WO2004044149A2 Method for suppressing immune system response to transplanted tissue or cells
05/27/2004WO2004044142A2 Mesenchymal stem cells and methods of use thereof
05/27/2004WO2004043481A2 Compositions containing peptide copper complexes and metalloproteinase inhibitors, and methods related thereto
05/27/2004WO2004043401A2 Method of preparing anti-angiogenic drug from cartillage and chondrocytes and methods of use
05/27/2004WO2004043232A2 Methods for identifying risk of melanoma and treatments thereof
05/27/2004WO2004043222A2 Treating carcinoid neoplasms with therapeuthic viruses
05/27/2004WO2004035616A3 Adenovirus expressing genes in reverse order and use thereof
05/27/2004WO2004033665A9 Heterologous plasma cocktail for hiv treatment
05/27/2004WO2004030628A9 Adult bone marrow derived stem cells
05/27/2004WO2003102169B1 Anaerobe targeted enzyme-mediated prodrug therapy
05/27/2004WO2003085123A8 Methods anc compositions for in vivo clearance of pathogens
05/27/2004WO2003060083A3 Cloning b and t lymphocytes
05/27/2004WO2003059276B1 Novel mammalian multipotent stem cells and compositions, methods of preparation and methods of administration thereof
05/27/2004WO2003044183A8 Interleukin-2 gene transferred lymphokine activated killer cells
05/27/2004WO2003033685A3 Method of producing human beta cell lines
05/27/2004WO2003015705A3 In situ immunization
05/27/2004WO2003006034A3 Herbal formulation
05/27/2004WO2003006033A3 Herbal formulation
05/27/2004WO2003002155B1 Vector encoding human globlin gene and use thereof in treatment of hemoglobinopathies
05/27/2004WO2002092827A3 Corona-virus-like particles comprising functionally deleted genomes
05/27/2004WO2002085304A3 Proliposomal drug delivery system
05/27/2004WO2002062362A8 Antiviral and antibacterial composition
05/27/2004WO2000073764A3 Composition and methods for the therapeutic use of an atonal-associated sequence
05/27/2004WO1999046281A8 Novel polypeptides and nucleic acids encoding the same
05/27/2004US20040103448 Using rodent animal model to monitor effectivenes of cell proliferation, viabilty and differentiation inhibitors
05/27/2004US20040102495 Synthesis of epothilones, intermediates thereto, analogues and uses thereof
05/27/2004US20040102410 In particular, invention relates to alphavirus-based, preferably Sindbis virus-based, vectors and to non-alphavirus-based vectors, which have a preferential affinity for high affinity laminin receptors
05/27/2004US20040102408 Method and medicament for inhibiting the expression of a given gene
05/27/2004US20040102373 Protein-induced morphogenesis
05/27/2004US20040101965 Paramyxovirus vector for gene transfer to the cardiovascular system
05/27/2004US20040101962 Dedifferentiated, programmable stem cells of monocytic origin, and their production and use
05/27/2004US20040101919 Detecting cell wall anchored surface proteins and developing vaccines to diagnose, prevent and treat enterococcus, streptococcus, staphylococcus and bacillus infections
05/27/2004US20040101915 Diagnosis and treatment of chemoresistant tumors
05/27/2004US20040101821 Antiviral antisense therapy
05/27/2004US20040101569 Extractable from bile of animals; stimulates monocytes and macrophages modulates tumor necrosis factor production; contains no measurable IL-1a, IL-1b, TNF, IL-6, IL-8, IL-4, GM-CSF or IFN- gamma; anti-proliferative, not cytotoxic, not
05/27/2004US20040101536 Vaccine formulations comprising antiidiotypic antibodies which immunologically mimic group B streptococcal carbohydrates
05/27/2004US20040101525 Heat resistance; controlling Clostridium, Campylobacter, Streptococcus; gastrointestinal disorders; bactericides
05/27/2004US20040101517 Central nervous system diosrders; Alzheimer's disease; Parkinson's disease; regeneration normal endothelial function; applying oxidation stresses to cells; angiotensin receptor antagonist
05/27/2004US20040101511 Combination preparation of a biological response modifier and an anticancer agent and uses thereof
05/27/2004DE10253066A1 Tissue substitute, useful for repairing lesions, e.g. in cardiac muscle, also for production of e.g. cytokines, comprises preformed three-dimensional tissue grown from suspension culture
05/27/2004CA2505523A1 Compositions containing peptide copper complexes and metalloproteinase inhibitors, and methods related thereto
05/27/2004CA2505251A1 Mesenchymal stem cells and methods of use thereof
05/27/2004CA2504903A1 Method for identifying risk of melanoma and treatments thereof
05/27/2004CA2502890A1 Treating carcinoid neoplasms with therapeutic viruses
05/26/2004EP1421948A2 Use of botulinum toxins for treating sweating in humans
05/26/2004EP1421945A1 Bile acid absorbent/adsorbent
05/26/2004EP1421539A2 Stabilized proteins with engineered disulfide bonds
05/26/2004EP1421199A2 Compositions and methods for treating neurodegenerative diseases
05/26/2004EP1421182A1 Methods of inducing differentiation of stem cells
05/26/2004EP1421181A1 ISOLATION OF INNER CELL MASS FOR THE ESTABLISHMENT OF HUMAN EMBRYONIC STEM CELL (hESC) LINES
05/26/2004EP1421180A2 Method of treating systemic inflammatory response syndrome
05/26/2004EP1421179A1 Isolation of cells from neural cell populations using antibodies to fa1/dlk1
05/26/2004EP1421174A2 Hematopoietic cell e-selection/l-selectin ligand polypeptides and methods of use thereof
05/26/2004EP1420821A2 Immunologically significant herpes simplex virus antigens and methods for using same
05/26/2004EP1420815A2 Beta-amyloid-analogue - t-cell epitop vaccine
05/26/2004EP1420814A2 Compositions and methods for the therapy and diagnosis of breast cancer
05/26/2004EP1420807A1 Platelet-derived growth factor protection of cardiac myocardium
05/26/2004EP1420803A1 Method for amplifying expression from a cell specific promoter
05/26/2004EP1420800A1 Modulation of insulin-regulated aminopeptidase (irap)/angiotensin iv (at 4) receptor activity
05/26/2004EP1420774A1 Preparation and diabetic use of gibberellins
05/26/2004EP1420716A1 An implantable and sealable system for unidirectional delivery of therapeutic agents to targeted tissues